Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341)

Archives of Gynecology and Obstetrics

Volumn 279, Issue 1, 2009, Pages 41-46

  Kamer, Serra ^a   Ren, Qing ^b   Dicker, Adam P ^b  

^a EGE UNIVERSITY   (Turkey)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; METABOLIC ACTIVATION; NITROBLUE TETRAZOLIUM TEST; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY; RADIOSENSITIZATION; UTERINE CERVIX CANCER;

BORONIC ACIDS; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; FEMALE; HELA CELLS; HUMANS; NF-KAPPA B; PROTEASE INHIBITORS; PYRAZINES; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; UTERINE CERVICAL NEOPLASMS;

EID: 56549108276     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-008-0667-7     Document Type: Article

References (40)

1. TD Gilmore 2006 Introduction to NF-κB: players, pathways, perspectives Oncogene 25 6680 6684
2. E Pikarsky RM Porat I Stein 2004 NF-κB functions as a tumor promoter in inflammation-associated cancer Nature 431 461 466
3. FR Greten L Eckmann TF Greten 2004 IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 285 296
4. Q Ren C Kari MR Quadros 2006 Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor κB signaling Cancer Res 66 10 5209 5215
5. J Cusack R Liu A Badwin 1999 NFκB and chemoresistance: potentiation of cancer chemotherapy via inhibition of NFκB Drug Resist Updat 2 271 273
6. TD Gilmore M Herscovitch 2006 Inhibitors of NF-κB signaling Oncogene 25 6887 6899
7. J Adams VJ Palombella EA Sausville 1999 Proteasome inhibitors: a novel class of potent and effective antitumor agents Cancer Res 59 2615 2622
8. CY Wang J Cusack R Liu 1999 Control of inducible chemoresistance enhanced anti-tumor therapy through increased apoptosis by inhibition of NFκB Nature Medicine 4 412 417
9. JB Sunwoo Z Chen G Dong 2001 Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma Clinical Cancer Res 7 1419 1428
10. S Williams C Pettaway R Song 2003 Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts Mol Cancer Ther 2 835 843
11. F Cardoso V Durbecq JF Laes 2006 Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner Mol Cancer Ther 5 12 3042 3051
12. A Goel A Dispensieri PR Greipp 2005 PS-341-mediated selective targeting of multiple myeloma cells by synergistic increase in ionizing radiation-induced apoptosis Exp Hematol 33 784 795
13. PJ Eifel 2006 Chemoradiotherapy in the treatment of cervical cancer Semin Radiat Oncol 16 3 177 185
14. A Nair M Venkatraman TT Maliekal 2003 NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix Oncogene 22 1 50 58
15. M Bradbury S Markovina SJ Wei 2001 Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-κB activation in HeLa Cells Occur via a mechanism involving p38 MAP Kinase Cancer Res 61 7689 7696
16. M Venkatraman RJ Anto A Nair 2005 Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis Mol Carcinog 44 1 51 9
17. S Gurska T Farkasova A Gabelova 2007 Radiosensitivity of cervical cancer cell lines: the impact of polymorphisms in DNA repair genes Neoplasm 54 3 195 201
18. A Saxena C Yashar DD Taylor 2005 Cellular response to chemotherapy and radiation in cervical cancer Am J Obstet Gynecol 192 1399 1403
19. SS Liu LYY Chan RCY Leung 2006 Enhancement of radiosensitivity of cervical cancer cells by overexpressing p73α Mol Cancer Ther 5 5 1209 1215
20. J Fogh JM Fogh T Orfeo 1977 One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice J Natl Cancer Inst 59 1 221 226
21. KM Ahmed JJ Li 2008 NF-Kappa B-mediated adaptive resistance to ionizing radiation Free Radic Biol Med 44 1 1 13
22. SE Chuang PY Yeh YS Lu 2002 Basal levels and patterns of anticancer drug-induced activation of NF-κB and its attenuation by tamoxifen, dexamethansone, and curcumin in carcinoma cells Biochem Pharmacol 63 1709 1716
23. S Shukla S Gupta 2004 Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes Clin Cancer Res 10 9 3169 3178
24. A Mishra AC Bharti P Varghese 2006 Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection Int J Cancer 119 12 2840 2850
25. C Didelot MB Heyob A Bianchi 2001 Constitutive NF-κB activity influences basal apoptosis and radiosensitivity of head-and-neck carcinoma cell lines Int J Radiat Oncol Biol Phys 51 1354 1360
26. CY Wang MW Mayo AS Baldwin 1996 TNF-α and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB Science 274 784 787
27. A Munshi JF Kurland T Nishikawa 2004 Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells Mol Cancer Ther 3 8 985 992
28. MS Mendonca H Chin-Sinex J Gomez-Millan 2007 Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappaB and split-dose repair Radiat Res 168 6 689 697
29. A Ciechanover 1998 The ubiquitin-proteasome pathway: on protein death and cell life EMBO J17 7151 7160
30. J Adams 2004 The proteasome: a suitable antineoplastic target Nat Rev Cancer 4 349 360
31. M Michaelis I Fichtner D Behrens 2006 Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo Int J Oncol 28 2 439 446
32. SM Russo JE Tepper AS Baldwin Jr 2001 Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB Int J Radiat Oncol Biol Phys 50 1 183 193
33. C Belka 2006 The fate of irradiated tumor cells Oncogene 25 7 969 971
34. C Jacquemont T Taniguchi 2007 Proteasome function is required for DNA damage response and fanconi anemia pathway activation Cancer Res 67 15 7395 7405
35. C Aghajanian S Soignet DS Dizon 2002 A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies Clin Cancer Res 8 8 2505 2511
36. R Dreicer D Petrylak D Agus 2007 Phase I/II study of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer Clin Cancer Res 13 4 1208 1215
37. JR Berenson HH Yang K Sadler 2006 Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma J Clin Oncol 24 6 937 944
38. Schmid P, Kühnhardt D, Kiewe P et al (2008) A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines. Ann Oncol [Epub ahead of print]
39. TL Lee XP Yang B Yan 2007 A novel nuclear factor-κB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status Clin Cancer Res 13 19 5680 5691
40. JH Lorch TO Thomas HJ Schmoll 2007 Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancer Cancer Res 67 727 734